These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
305 related items for PubMed ID: 10969774
1. Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancer. Nass SJ, Herman JG, Gabrielson E, Iversen PW, Parl FF, Davidson NE, Graff JR. Cancer Res; 2000 Aug 15; 60(16):4346-8. PubMed ID: 10969774 [Abstract] [Full Text] [Related]
2. Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer. Umbricht CB, Evron E, Gabrielson E, Ferguson A, Marks J, Sukumar S. Oncogene; 2001 Jun 07; 20(26):3348-53. PubMed ID: 11423985 [Abstract] [Full Text] [Related]
4. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer. Caldeira JR, Prando EC, Quevedo FC, Neto FA, Rainho CA, Rogatto SR. BMC Cancer; 2006 Mar 02; 6():48. PubMed ID: 16512896 [Abstract] [Full Text] [Related]
5. Methylation of estrogen and progesterone receptor gene 5' CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors. Lapidus RG, Ferguson AT, Ottaviano YL, Parl FF, Smith HS, Weitzman SA, Baylin SB, Issa JP, Davidson NE. Clin Cancer Res; 1996 May 02; 2(5):805-10. PubMed ID: 9816234 [Abstract] [Full Text] [Related]
6. Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ. Helczynska K, Kronblad A, Jögi A, Nilsson E, Beckman S, Landberg G, Påhlman S. Cancer Res; 2003 Apr 01; 63(7):1441-4. PubMed ID: 12670886 [Abstract] [Full Text] [Related]
7. Tumor-derived aberrant methylation in plasma of invasive ductal breast cancer patients: clinical implications. Hu XC, Wong IH, Chow LW. Oncol Rep; 2003 Apr 01; 10(6):1811-5. PubMed ID: 14534701 [Abstract] [Full Text] [Related]
9. Mapping of ER gene CpG island methylation-specific polymerase chain reaction. Lapidus RG, Nass SJ, Butash KA, Parl FF, Weitzman SA, Graff JG, Herman JG, Davidson NE. Cancer Res; 1998 Jun 15; 58(12):2515-9. PubMed ID: 9635570 [Abstract] [Full Text] [Related]
11. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer. Yan PS, Shi H, Rahmatpanah F, Hsiau TH, Hsiau AH, Leu YW, Liu JC, Huang TH. Cancer Res; 2003 Oct 01; 63(19):6178-86. PubMed ID: 14559801 [Abstract] [Full Text] [Related]
12. Distinct patterns of E-cadherin CpG island methylation in papillary, follicular, Hurthle's cell, and poorly differentiated human thyroid carcinoma. Graff JR, Greenberg VE, Herman JG, Westra WH, Boghaert ER, Ain KB, Saji M, Zeiger MA, Zimmer SG, Baylin SB. Cancer Res; 1998 May 15; 58(10):2063-6. PubMed ID: 9605742 [Abstract] [Full Text] [Related]
14. [Detection of free tumor-related DNA in the serum of breast cancer patients]. Zhang JJ, Ouyang T, Wan WH, Deng GR. Zhonghua Zhong Liu Za Zhi; 2007 Aug 15; 29(8):609-13. PubMed ID: 18210882 [Abstract] [Full Text] [Related]
15. Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Ottaviano YL, Issa JP, Parl FF, Smith HS, Baylin SB, Davidson NE. Cancer Res; 1994 May 15; 54(10):2552-5. PubMed ID: 8168078 [Abstract] [Full Text] [Related]
17. Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas. Toyooka KO, Toyooka S, Virmani AK, Sathyanarayana UG, Euhus DM, Gilcrease M, Minna JD, Gazdar AF. Cancer Res; 2001 Jun 01; 61(11):4556-60. PubMed ID: 11389090 [Abstract] [Full Text] [Related]
19. Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients. Mirza S, Sharma G, Prasad CP, Parshad R, Srivastava A, Gupta SD, Ralhan R. Life Sci; 2007 Jul 04; 81(4):280-7. PubMed ID: 17599361 [Abstract] [Full Text] [Related]